<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR-OCB-15007054</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2015-09-13</date_registration>
      <primary_sponsor>Institute of zoology, chinese academy of sciences</primary_sponsor>
      <public_title>Clinical study of subretinal transplantation of clinical human embryonic stem cells derived retinal pigment epitheliums in treatment of dry age-related macular degeneration diseases</public_title>
      <acronym />
      <scientific_title>Clinical study of subretinal transplantation of clinical human embryonic stem cells derived retinal pigment epitheliums in treatment of dry age-related macular degeneration diseases</scientific_title>
      <Scientific_acronym />
      <date_enrolment>2015-09-10</date_enrolment>
      <type_enrolment />
      <target_size>One cohort:10;</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=11872</url>
      <study_type>Observational study</study_type>
      <study_design>Before-After control</study_design>
      <phase>New Treatment Measure Clinical Study</phase>
      <hc_freetext>Dry age-related macular degeneration diseases</hc_freetext>
      <i_freetext>One cohort:retinal pigment epithelium transplantation;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>Hao Jie</firstname>
        <middlename />
        <lastname />
        <address>25-2 North 4th Ring, Haidian District, Beijing</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 010 62558737</telephone>
        <email>haojie@ioz.ac.cn</email>
        <affiliation>Institute of zoology, chinese academy of sciences</affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>Zhou Qi</firstname>
        <middlename />
        <lastname />
        <address>1-5 West Beichen Road, Chaoyang District, Beijing</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 010 64807299</telephone>
        <email>zhouqi@ioz.ac.cn</email>
        <affiliation />
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1. Aged 55-70 ys;
2. Diagnosed as atrophic age-related macular degeneration;
3. No CNV;
4. The BCVA of target eye will not be better than 20/400;
5. Diopter is greater than 8.00 D, axial length â‰¤28 mm;
6. Voluntary as test subjects, signed informed consent, regular follow-up will be effected according to the specified time.</inclusion_criteria>
      <agemin>55</agemin>
      <agemax>70</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1. The macular atrophy  caused by other disesaes in addition to AMD;
2. With history of other eye diseases or ocular traumas;
3. With history of intraocular surgery;
4. With serious systerm diseases, ALT/AST)&gt; 1.5 or creatine &gt; 1.3 mg/dL;
5. With any immunodeficiency disease;
6. Subject who are receiving immunosuppressive therapy;
7. Allergic to tacrolimus or Mycophenolate mofetil;</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Early treatment of diabetic retinopathy eye chart (ETDRs);Best corrected visual acuity;Fluorescein angiography;Optical coherent tomography (OCT);mutifocal electroretinogram (MFERG);Flash electroretinogram (FERG); HRA autofluorescence;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome />
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Strategic Priority Research Program of the Chinese Academy of Sciences (XDA01030000)</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2016-01-26</approval_date>
        <contact_name />
        <contact_address />
        <contact_phone />
        <contact_email />
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>